Skip to main content

Table 1 Overview of the primary antibodies used in the present study

From: Acute minocycline administration reduces brain injury and improves long-term functional outcomes after delayed hypoxemia following traumatic brain injury

Antibody

Fluorophore

Clone

Species

Dilution

Source

Product number

Tissue

In vitro

IHQ

FC

CD45

BV425

30-F11

Rat monoclonal

 

1:200

BioLegend

103134

CD3É›

AF700

500-A2

Armenian Hamster monoclonal

 

1:100

BioLegend

100320

CD11b

BV510

M1/70

Rat monoclonal

 

1:500

BioLegend

101263

MHC-II

PerCP-710

AF6-120.1

Mouse monoclonal

 

1:200

eBioscience

46-5320-80

TLR4

PE-Cy7

SA15-21

Rat monoclonal

 

1:250

BioLegend

145407

Ly6C

BV785

HK1.4

Rat monoclonal

 

1:2000

BioLegend

128041

Ly6G

AF700

1A8

Rat monoclonal

 

1:100

BioLegend

127622

NeuN

 

A60

Rabbit polyclonal

1:4000

 

Millipore

MAB377

Iba1

 

NCNP24

Rabbit polyclonal

1:1000

 

Wako

019-19741

CD68

 

Gp110

Rabbit polyclonal

1:1000

 

Invitrogen

PA5-32330

PDGFR-α

  

Goat polyclonal

1:250

 

R & D systems

AF1062

PSD-95

  

Rabbit polyclonal

1:200

 

Invitrogen

51-6900

Synapsin

  

Guinea Pig

1:1000

 

Synaptic systems

106 004

Secondary antibody

AF488

 

Goat anti-rabbit

1:500

 

Thermo Fisher

A-32731

Secondary antibody

AF568

 

Goat anti-guinea pig

1:500

 

Thermo Fisher

A-11073

Secondary antibody

AF568

 

Donkey anti-goat

1:500

 

Thermo Fisher

A-11055

Secondary antibody

AF488

 

Donkey anti-rabbit

1:500

 

Thermo Fisher

A-21206

Secondary antibody

  

Biotinylated goat anti-rabbit

1:1000

 

Vector Laboratories

BA-1000-1.5